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1. INTRODUCTION.      
Plants are one of the important sources of medicine. The 
application of plants as medicine dates back to prehistoric period. Several 
indigenous drugs used in modern medicine have figured in ancient 
manuscripts such as Rigved, the Bible, and Quran. Over six thousand 
years ago, the ancient Chinese were the first to use the natural vegetation 
as medicine. In India, the Ayurvedic system of medicine has been in use 
for over three thousand years. Hippocrates, the 'Father of Medicine' was 
the first to give a scientific explanation of diseases. Indian system's of 
medicine includes Ayurveda, Siddha, Unani, Tibetan and Naturopathy. 
Herbal therapy provides rational means for the treatment of many internal 
diseases which are considered to be obstinate and incurable in other 
systems of medicine. It aims at both the prevention and cure of diseases.  
1.1 HISTORY OF HERBAL DRUGS 
Thousand years ago many natural drugs were identified for 
combating human ailments either by instinct or intuition or trial and error 
methods. The earliest mention of medicinal use of plants has been used 
found in 'Rig Veda', which was written between 4000 and 1600 B.C. In 
the "Atharva Veda", we find the more varied use of drugs. It is the 
“Ayurveda “which is considered as an    “Upa  Veda " that definite 
properties of drugs and their uses have been given in great detail.  
"Charka samhita" is another earliest treatise on "Ayurveda" (600 BC), 
which lists a total of 341 plant produce for use health management.  
"Sushruta Samhita" also dealt with plants related to medicine.  
Dhanvantari and  Nagarjuna were the well known person with an 
intimate knowledge of the characteristics of medicinal plants. Rauwolfia, 
which has acquired world wide popularity, finds mention in ancient 
Hindu scriptures as well as in the monumental work of charaka.  The 
plant was mentioned as usefull antidote for snake bites and insect stings.
 
(1) 
Their effectiveness, easy availability, low cost, and comparatively 
being devoid of serious toxic effect (time tested) popularized herbal 
remedies. Medicinal plants have their values due to the presence of 
chemical constituents, commonly known as secondary metabolites, 
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present in various plant tissues. These substances are alkaloids, 
glycosides, essential and fatty oils, resins, gums, mucilage, tannins etc. of 
large use. These active principles may be present in the organs of the 
plant, viz-roots, seeds, leaves, bark, wood etc... 
(2)
   
Popularity of herbal medicine over allopathic medicine is because of the 
following reasons:- 
 Low cost of medicine 
 Relatively free from side effects 
 Cures the root cause and remove it 
 Cures for many obstinate diseases  
 Easy availability (3) 
1.2 SCOPE OF HERBAL MEDICINES: 
Several civilizations across the globe have herbs in different forms. 
Before the advent of modern medicine herbs were used in the form of 
powders, pastes, tablets, galenicals like tinctures, infusion, decoction, oils 
saturated with herbs, oils, poultice etc. Herbs have been used in India in 
Ayurveda, Sidda, Unani systems of medicine, collectively known as 
indigenous system of medicine. The modernized method of formulating 
herbal medicines has yielded a new system of herbal medicine, popularly 
known as phytomedicine. The Ayurvedic medicines can be classified as 
like Charak samhita, Sushrut samhita, Bharat Bheshaj Ratnakar etc. and 
Ayurvedic proprietary medicine. 
          In developed countries, particularly in the United States of 
America, the herbal formulations are included in the list of food 
supplements and are considered as alternative or complementary system 
of medicines. Several clinical trials on herbal extract have been 
undertaken to prove their safety and efficacy using protocols acceptable 
to the modern medicines. Many developed countries have realized the 
usefulness of herbs as a sourse of starting material (lead compounds) in 
the process of drug discovery. The chances of getting new drugs from 
herbs are more than getting anew drugs from synthetic source because of 
availability of literature on plant activity. Many biomarkers have been 
isolated and identified 
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          There is fundamental difference between the indigenous system of 
medicine and modern medicine. The modern medicine makes use of 
single ingredient whereas the indigenous system of medicine believes that 
different constituents of herbs have synergistic effect. It has been shown 
that mode of action differs when effect of isolation biomarkers is 
compared with the total extracts. 
(4)
  
 
2. PAIN          
Algesia (pain) is an ill-defined, unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, which varies 
from person to person and in the same person, from time to time. 
Unrelieved acute pain can cause chronic pain and long standing pain can 
cause anatomical and even genetic changes in the nervous system. Pain is 
warning signal, primarily protective in nature, but causes discomfort and 
suffering. Excessive pain may produce other effects such as sinking 
sensation, apprehension, sweating, nausea, palpitation, and rise or fall in 
BP, tachypnoea 
2.1 TYPES OF PAIN  
 Stimulation of a nociceptor, due to a chemical, thermal, or 
mechanical event that has the potential to damage body tissue, may 
cause nociceptive pain 
(5)
 
 Damage to the nervous system itself, due to disease or trauma, may 
cause neuropathic (or neurogenic) pain. Neuropathic pain may 
refer to peripheral neuropathic pain, which is caused by damage to 
nerves, or to central neuropathic pain, which is caused by damage 
to the brain, brainstem, or spinal cord. 
  Nociceptive pain and neuropathic pain are the two main kinds of 
pain when the primary mechanism of production is considered. 
Nociceptive pain may be classified further in three types that have 
distinct organic origins and qualities. 
1. Superficial somatic pain (or cutaneous pain): Is caused by injury 
to the skin or superficial tissues. Cutaneous nociceptors terminates 
just below the skin, and due to  the high concentration of nerve 
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endings, produce a sharp, well-defined, localized pain of short 
duration. Examples of injuries that produce cutaneous pain include 
minor wounds, and minor (first degree) burns. 
2. Deep somatic pain: It originates from ligaments, tendons, bones, 
blood vessels, fasciae, and muscles. It is detected with somatic 
nociceptors. The scarcity of pain receptors in these areas produces 
a dull, aching, poorly-localized pain of longer duration than 
cutaneous pain: examples include sprains, broken bones, and 
myofascial pain. 
3. Visceral pain: Originates from body's viscera, or organs. Visceral 
nociceptors are located within body organs and internal cavities. 
The even greater scarcity of nociceptors in these areas produces 
pain that is usually more aching or cramping and of a longer 
duration than somatic pain. Visceral pain may be well localized, 
but often it is extremely difficult to localize, and several injuries to 
visceral tissues exhibit "referred" pain, where the sensation is 
localized to an area completely unrelated to the site of injury.
(6)
  
2.2 CAUSES OF PAIN 
      Pain can be caused by many different factors. Conditions that 
accompany normal aging may affect bones and joints in way that cause 
pain. Normal body pain is formed due to some common health conditions 
such as, 
 Muscle Knots 
 Sensitization 
 Brain pain 
 Pathological sensitization 
 Vitamin D deficiency 
 Muscle tension and contracture  
 Referred pain 
 The pain of stuckness 
 Drug side effect, especially bisphosphonates and 
statins 
 Analgesic rebound.(7) 
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 2.3 DIAGNOSIS OF PAIN 
The medical community is full of tests to try to finds the cause of 
pain or disease. However, the real cause of your chronic, severe pain may 
be difficult to diagnose using labs and diagnostic tests. Imaging tests are 
also called radiological test. With these tests, the doctor uses different 
technologies to get a better picture of what's going on in the body-with 
the bones, soft tissues, and organs. 
Here are the most common imaging tests: 
 X-ray 
 CT scan 
 MRI 
 Nerve blocks 
 Discography 
 Myelogram 
 Ultrasound imaging (8) 
2.4 TREATMENT OF PAIN 
 Pain is complex, so there are many treatment options - medication, 
therapies, and mind –body techniques. Some measures you can take to 
relives pain from injuries 
 Resting the area of the body where you are experiencing 
aches and pains. 
 Applying ice to the affected area to help relives pain and 
reduce inflammation. 
 Taking an over-the- counter pain reliever, or analgesic 
drugs such as Acetaminophen, NSAIDs such as aspirin, 
ibuprofen etc. 
(9)
  
2.5 ANALGESICS 
A drug that selectively relives pain by acting in the CNS or on 
peripheral pain mechanisms, without significantly altering consciousness. 
A wide range of drugs are used to control pain. They range from mild 
over-the-counter (OTC) drugs, such as aspirin and acetaminophen, to 
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strong general anaesthetics. Drugs that relieve pain often reduce fever and 
inflammation that are used to treat conditions such as 
 Mild to moderate pain caused by injury or surgery 
 Fever, headaches, and painful menstruation  
 Rheumatoid arthritis ( a chronic inflammatory disease of  
the peripheral joints) 
 Osteoarthritis (a chronic disease that involves wear and 
deterioration of joints in the body, causing inflammation) 
 Chronic pain associated with cancer, AIDS, multiple 
sclerosis, or sickle cell disease 
 
 Some commonly used Analgesic drugs are  
 Acetaminophen 
 Acetanilide 
 Morphine 
 Aspirin 
 Caffeine 
 Codeine 
 Ibuprofen 
 Tylenol 
 Medical cannabis (10) 
 
 2.6 CLASSIFICATION OF ANALGESICS 
A drug that selectively relieves pain by acting CNS or on the 
peripheral pain mechanism. Without significantly altering consciousness 
is called an analgesic.    
       Analgesics are divided into two groups: 
 Opioids /Narcotics/Morphine like analgesics 
 Nonopioid/Non-narcotic/Aspirin like/antipyretic/anti-
inflammatory analgesics 
 
                                                                                        
INTRODUCTION 
 
Department of Pharmacology Page 7 
 
 2.6.1 OPIOIDS ANALGESICS 
 It was introduced in Britain at the end of 17
th
 century, usually 
taken orally as “Tincture of laudanum”. These are the substance that can 
be endogenous or synthetic, which produce morphine like effect.  It is a 
dark brown, resinous material obtained from poppy (papaver 
somniferum), capsule. 
 
       It contains two types of alkaloids: 
              A. Phenathrene derivatives 
                           Morphine (10% in opium) 
                           Codeine (0.5% in opium) 
                           Thebaine (0.2% in opium) 
 
             B. Benzylisoquinoline derivatives 
                           Papaverine (1% in opium) 
                           Noscapine (6% in opium)  
USES- Used for thousands of years to produce: 
- Euphoria  
- Analgesia 
- Sedation 
- Relief from diarrhea 
- Cough suppression (11) 
2.6.2 OPIOIDS RECEPTORS 
There are 4 types of opioid receptors, with multiple receptor 
subtypes:   
Mu- These receptors produce the most profound analgesia, and can cause 
euphoria, 
Kappa- These contribute to analgesia at spinal level. These receptors 
trigger a lesser analgesic response, 
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Delta- These receptors modulate mu receptors activity  
Sigma- These receptors provide little to no analgesia 
(11) 
2.6.3 MECHANISM OF ACTION 
All opioid receptors are G –protein coupled receptors, stimulation 
of these receptors inhibits adenylate cyclase resulting in decreased 
intercellular cAMP formation. They also facilitate the opening K+ 
channels leads to hyperpolarisation and inhibit the entry of calcium into 
the cell. In addition to this they inhibit the opening of calcium channels. 
All these results in a decrease in the intercellular calcium which, in turn, 
decrease the release of neuron transmission of pain impulses. 
                                     Opioids also directly inhibit the transmission in 
the dorsal horn ascending pathway. 
(12) 
 
 
Figure 1: mechanism of action of analgesic drug 
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2.7 ANIMAL MODELS FOR EVALUATING CHRONIC PAIN 
Animal tests are in the search for new analgesics are desinged as 
models for the treatment of pathological pain in man; but they usually 
differ from the orginal in that the drug is given before the noxious 
stimulus (thermal, electrical, chemical, and mechanical types of 
stimuli).
(13)
 Hence, these tests only measure the power of a drug to 
increase the minimal stimulus requiredto elicit pain or nociceptive 
response. The methodology to perform these tests using above stimuli is 
described below. 
 Hot plate methods  
 The tail immersion test 
 Writhing test 
3. FEVER 
Fever also known as pyrexia is defined as a temperature higher 
than 38.3ºC(100.9ºF) that lasts for more than three weeks with no obvious 
source despite appropriate investigation. It is a pathologic elevation of the 
normal body temperature; it is an active process and resists changes by 
the external enviornment. Fever is not a disease, but merely a sign of 
many different disease. Body temperature may be raised without 
pathological causes, as in excecise or in hyoerthermia resulting from 
excessive exposure to heat. Fever  is usually a sign of infection in the 
body. Infections suchnasncolds and flu are very common, especially in 
preschool children. 
(14)
  
Fever is most often caused by virus and sometimes by  bacteria. 
Viral infections are common and do not need antibiotics as they do not 
cure viruses. Bacterial infections are usually treated with antibiotics. It is 
the body's natural response to help fight infection. fever itself is not 
harmful, so it is usually not necessary to treat fever. 
 
3.1 TYPES OF FEVER  
There are mainly four types of fever based on the fluctuation of body 
temperature 
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 Intermittent : The body temperature alternates between fever and 
normal at regular intervels 
 Remittent   :  The body temperature always above normal but 
fluctuates in wide ranges 
 Relapsing   : The fluctuations occurs between days. le : Week of 
fever followed by week of normal. 
(15)
 
 Constant      : Minimal fluctuation. Always above normal 
3.2 STAGES OF FEVER 
1. The chill phase: or a period of raising temperature. A chill amy 
last few minites it may reach an hour. 
Patients experience a feeling of cold and shivering, skin is cool 
and pale 
2. The course of fever: when the temperature is maintained at an 
elevated level. The skin feels warm and flushed 
The patients feels-thrist, malaise, weakness, aching muscle and 
drowing or restless. 
 
3. The terminatiohn orn decline period: it is a periods when 
temperature falls to normal either by: 
        a- Crisis: the temperature falls quickly over  a periods of few 
hours 
        b- lysis: the temperature falls gradually over a period of days or 
weeks 
                Ashort lysis takes about 3 days 
               A long lysis takesnfrom 7 to 10 days. 
(16)
      
3.3 CAUSE OF FEVER 
 Exogenous pyrogens: derived from outside sn individual and may 
include LPS and toxins. 
 Endogenous pyrogens: originating inside the body and many 
include pyrogenic cytokines, IL-1,IL-6,TNF. 
 Damage to heat- regulating centre due to head 
injuries.cerebrovascular accidents and abnormally high body 
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temperature. This leads to disturbance in the heat regulating 
mechanisam. 
 Acute infections disease.  
 Acute and prolonged pain. 
 Extreme nervousness. 
 Emotional stress.  
 Trauma or injury to body tissues. (17) 
3.4 SIGNS AND SYMPTOM OF FEVER 
 Rapid pulse 
 Rapid shallow respiration 
 Cold, then hot skin  
 Headache  
 Sweating and shaking chill 
 Restlessness 
 Anorexia 
 Nausea and vomiting 
 Dehydration 
 Constipation 
 Decrease urinary out put (oliguria) 
 Sweating   
 Appetite loss (18) 
 3.5 COMPLICATIONS OF FEVER 
 Sinusitis 
 Step throat 
 Brochitis 
 Pneumonia 
 Brochiolitis 
 Croup 
 Sleep disruption 
 Physical difficulities (19) 
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3.6 DIAGNOSIS OF FEVER 
Q fever, caused by Coxiella burnetii, should be included in the 
differential diagnosis of acute neurologic disease in a patient with fever. 
Patients with acute Q fever infection have frequent neurologic symptoms, 
varying from a severe headache in most of the patients to confusion, but 
rarely meningitis. 
The first step is accurate recording of core body temperature. A 
rectal thermometer is more reliable than skin surface or buccal 
recordings. The temperature is monitored constantly in an intensive care 
setting. Basic laboratory investigations include blood counts, serum 
electrolytes, blood urea nitrogen, creatine, and liver function tests. 
(20)
 
Further investigations of the cause depend on the clinical features and 
suspected pathology. The predominant causes are infections. Gene 
expression profiles of blood leukocytes in febrile children can help to 
discriminate viral from bacterial causes of fever without an apparent 
source. Several biomarkers have been used to differentiate infections 
from inflammatory or malignant causes of fever, but commonly used 
biomarkers, such as C reactive protein, do not have enough sensitivity or 
specificity to guide treatment decisions, and procalcitonin is considered to 
be the most helpful laboratory biomarker for this purpose.
 (21)
 
Cerebrospinal fluid is examined and cultured if meningitis is considered 
as a clinical diagnosis 
 
 
3.7 TREATMENT OF FEVER 
 
When the presence of fever is contra-indicated in a patient, what 
then are the most effective ways of reducing temperature? Traditional 
methods have relied on administering antipyretic drugs, such as 
paracetamol, and external cooling procedures, such as tepid sponging. 
When the skin is cooled by tepid sponging, the body detects a difference 
between the thermostatic set point and the peripheral thermoreceptors.
(22)
 
The warming response which this triggers to bring the temperature 
detected at the peripheral thermoreceptors to the thermostatic set point is 
counterproductive and can be distressing for the patient because of the 
violent shivering that can occur. 
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Antipyretics are drugs that decrease fever. Fever is a pathologic elevation of the normal 
Antipyretics are drugs that decrease fever. Fever is a pathologic 
elevation of the normal body temperature; it is an active process and 
resists changes by the external environment. Fever is not a disease, but 
merely a sign of many different diseases. Body temperature may be raised 
without pathologic causes, as in exercise or in hyperthermia resulting 
from excessive exposure to heat. 
In the SGH, the antipyretic drug of choice is paracetamol. 
Rosenthal and Silverstein (1988), say salycilates have been available and 
used to control temperature since the 1880s. Antipyretic drugs, such as 
aspirin, paracetamol and ibuprofen, do not stop the production or actions 
of cytokines but block the action of the enzyme cyclo-oxygenase which is 
essential for the production of prostaglandins in the brain. When the 
thermostatic set point has returned to normal, cooling begins and the body 
temperature falls. Antipyretic drugs also relieve arthritis and myalgia 
associated with fever by blocking the production of prostaglandins at the 
joints and muscles.  In addition, they do not interfere with the immune 
response to pyrogen activity and are useful in relieving the discomfort of 
a feverish illness. 
Some antipyretic drugs, 
 
 NSAIDS Such as ibuprofen, ketoprofen and nimesulide 
 Aspirin and related salicylates such as choline salicylate, 
magnesium salicylate and sodium salicylate 
 Paracetamol ( USAN and JAN acetaminophen) 
 Metamizole, banned in over 30 countries for causing 
agranulocytosis 
 Nabumetone 
 Phenazone (antipyrine), available in combination with benzocaine 
as an ear drop in the US  
 
3.8 MECHANISM OF ACTION OF ANTI-PYRETIC DRUGS 
      
Fever is a complex physiologic response triggered by infectious or 
aseptic stimuli. Elevations in body temperature occur when concentration 
of prostaglandin E (2) (PGE(2) increase within certain areas of the brain. 
These elevations alter the firing rate of neurons that control 
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thermoregulation in the hypothalamus. Drug that blocks pyrogen-induced 
prostaglandin production in thermoregulatory center (CNS). It will reduce 
the heat production.
 (23, 24)
 
 
 
4.INFLAMMATION 
Inflammation or phlogosis is pathological response of living tissue 
to injuries that leads to the local accumulation of plasmatic fluid and 
blood cell. Although it is defense can be induced, maintain or aggravate 
many disease. 
(25)
 It is a complex phenomenon, comprising of 
biochemical as well as immunological factors. Inflammation is 
recognized by following symptoms: 
                              1. Rubor (redness) 
                                        2. Tumor (Swelling) 
                                        3. Calor (heat)  
                                        4. Dolor (pain) 
                                        5. Functio laesa (Loss of functions) 
(26) 
 
4.1 TYPES OF INFLAMMATION 
Depending up on thedefence capasity of he host and duration of 
response, Mainly three types of inflammation are recognized or 
inflammatory response occurs in two distinct phases, each apparently 
mediated by different mechanisms. Based on the course and duration, the 
inflammation can be called as: 
Acute: 
Inflammation is the response of living to damage. The acute 
inflammatory response has 3 main functions. 
 The affected area is occupied by a transient material called the 
acute inflammatory exudate. The exudate carries proteins, fluid and 
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cells from local blood vessels into th damaged area to mediate local 
defenses. 
 If an infective causaitive agent (e.g. bacteria) is present in the 
damaged area it can be destroyed and eliminated by components of 
the exudate. 
 The damaged tissue can bebroken down and partially liquefied, and 
the debris removed from then site of damage. 
The cause of acute inflmmation may be due tophysical damage, 
chemical substances, micro-organisms or other agents. The inflammtory 
response consists of changes in blood flow, increased permeability of 
blood vessels and escape of the cell from into the tissues. It is 
characterized by local vasodilation and increased capillary permeability. 
It is immediate and early response to injuries agents have three major 
components. 
 
1) Increase in blood flow. 
2) Structural changes that leads to plasma protein and 
leukocytes into circulation. 
3) Accumulation of leukocyte in focus of injury. 
Sub-Acute: 
The inflammation lasts for 1 to 6 weeks or more. The type that is 
neither acute nor chronic is termed as sub-acute inflammtion. It lasts 
longer as compared to acute inflammation. Microscopically vascular, 
exudative as well as proliferative changes of acute and chronic 
inflammation are present. Exudate chiefly consists of eosinophils, 
lymphocytes, plasma cells, histocytes and fibroblasts. 
Chronic: 
Chronic inflammation as consideredto be of prolonged duration 
(weeks or month) in which active inflammation, tissue destruction and 
attempts at healing are proceeding simultaneously.
(27)
 Chronic 
inflammation frequently begins insidously as a low grade, smoldering 
after asymptomatioc response and examplesn include rhematoid arthiritis, 
atherosclerosis, tuberculosiis etc. 
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Chronic inflammation is characterized by: 
a) Inflammation with mononuclear cells. 
b) Tissue destruction 
c) Repair by connective tissue replacements 
4.2 MECHANISM OF INFLAMMATION: 
Inflammation process is continues process operating through many 
mechanisms. Histopathological and biochemical studies of inflammation 
indicate that it involves two distinct events: 
A. Vascular events 
B. Cellular events (leucocytic infiltration) 
It contains:- 
a) Changes in vascular flow and caliber 
b) Vascular leakage 
 
Figure 2: process of inflammation 
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a) Changes in vascular flow and caliber: 
It begins early after injury and proceeds at different rates 
depending on severity of injury. Changes occurs in the following manner: 
  After an inconstsnt and transient vasoconstriction of arterioles, 
lasting few seconds, vasodilation occurs. Vasodilation first involves the 
arterioles and then results inthe opening of new capillary beds in the area. 
This along with increased blood flow, which is the casuse of heat and 
redness. Different mediator are involved in this process of vasodilation 
suchnas vasoactive amines, kinins and prostagladins.
(28)
 Slowing of 
circulation is brought about by increased permeability of 
microvasculature, with outpouring of protein rich fluid into extravascular 
tissues. 
- Stasis – develops due to loss of fluid, which results in coincentraion of 
red cells in small vessels and increased viscocity of the blood 
- After this there occurs peripheral orientation of leukocytes,a process 
called leukocytic migration 
b) Vascular Leakage: 
Increased vascular permeability leading to the escape of protein 
rich fluid is the hallmark of acute inflammation. In normal conditions, 
fluid loss through the vascular bed is governed by the balance between 
hydrostatic and pressure in the venular end.  Increase in capillary 
hydroststic pressure resulting from local vasodilation after an 
inflammatory injury drives fluid out of the vascular compartment and 
extra vascular spaces at the rate that is too rapid for reabsorption by 
lymphatic to prevent the resulting edema formation and tissue swelling.  
Three phases of vascular permeability are 
(29) 
I. Immidiate-Transient phase: This lasts about 30 min. Affects 
venules and is largely mediated by histamine. 
II. Immediate- Prolonged phase: The exudation starts immediately 
but persists for days. It appears to be due to direct damage to 
vessels. 
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III. Delayed prolonged phase: Both capillaries and venules are 
affected by the direct injury of the agent(e.g heat) and by 
chemical mediators. 
B) Cellular Events:   
A critical function of inflammation is the delivery of leukocytes to 
the site of injury. Leukocytes ingest offending agents, kill bacteria and 
other microbes and degrade necrotic tissue & foreign antigens. 
Leukocytes may also prolong inflammation and induce tissue damage by 
releasing enymes, chemical mediators and toxic oxygen radicals. The 
migration of leukocytes at the sutes of inflammation takes place as 
follows  
 
4.3 CAUSES OF INFLAMMATION 
Microbial infection: 
One of the most common causes of inflammation is microbial 
infection. Microbes include viruses, bacteria, protozoa, fungi, various 
parasites. Viruses lead to death of individual cells by intracellular 
multiplication, and either cause the cell to stop fuctioning and die, or 
cause explosion of the cell (cytolytic), in which case it also dies. 
Hypersensitivity reaction: 
A hypersensityvity reaction occurs when an altered state of 
immunolaogic responsiveness causes an inappropriate or expessive 
immune reaction that damages the tissues. The types of reaction will be 
disscussed in more detail later (in the lesson on immune mediated 
inflammation) 
Physical agents, irritant and corrosive chemicals: 
Tissue damage leading to inflammation may occur through 
physical trruma, ultravoilet or other ionizing radiation, burns or execssive 
cooling ('frostbite'). Corrosive chemicals(acid, alkalis, oxidizing,agents) 
provoke inflammtion through direct tissue damage. These chemical 
irritant cause tissue damage that leads directly to inflammation.
(30) 
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Tissue necrosis: 
Death of tissue from lack of oxygen or nutrients resulting from 
inadequate blood flow (infraction) is a potent inflammatory stimulus. The 
edge of recent infract often shows an acute inflammatory response.  
4.4 DIAGNOSIS OF INFLAMMATION 
            Most commonly measured: 
 Fever 
 Cell Blood Count 
 Erythrocyte Sedimentaion Rate 
 C-reactive protein 
 Procalcitonin (31) 
4.5 TREATMENT OF INFLAMMATION 
To reduce inflammation and the resulting swelling and pain, 
injured tissue need to be properly treated. The earilier you start 
traetment,the better.  
      The treatment of acute inflammation consist of “R.I.C.E” therapy- 
Which stands for Rest, Ice, Compression, Elevation. For acute 
inflammation in the foot or ankle, your foot ankle surgeon will 
recommend the following: 
 Rest: Stay off of your foot as much as possible to prevent further 
injury. In some cases, complete immobilization may be required. 
Your doctor will decide whether you will need crutches and 
whether movement of your foot ankle is appropriate. 
 Ice: Icing, which decreses blood flow to the tissue, thus reducing 
swelling and pain, should be continued until your symptoms 
resolve. Wrap ice cubes- or a bag of frozen peas or corn-in a thin 
towel and place the pack on the injured area for 20 mintues of 
each hour you're awake. If your skin turns blue or white, 
discontinue icing for a few hours. Two cautions: never apply ice or 
frozen bags directly to your skin. And never leave an ice pack on 
your injury while you sleep. 
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 Compression: keep the inflammed area compressed by wrapping 
it in an elastic bandage or stocking. Compression prevents 
additional fluid acumulation and helps reduce pain. Wrap the 
bandage more firmly at the toesand less firlmy at the calf. If your 
toes tingle or your foot throbs, the wraping may need to be 
loosening the wrap, contact your doctor as soon as possible. 
 Elevation: keeping the foot elevated reduce the swelling by 
allowing excess fluid is to drain to the heart. The proper way to 
elevate your foot is to keep it level with or slightly above the heart. 
Place one or two pillows under your hip and knee are slightly bent. 
Never keep your leg extended straight out.
(32)
 
      In addition to the above measures, your foot and ankle surgeon 
may prescribe a nonsteriodal anti inflammatory drug (NSAID), 
such as ibuprofen, or another type of medication. 
   
Commonly used anti inflammatory drugs 
 Diclofenac  
 Ibuprofen 
 Indomethacine 
 Ketoprofen 
 Naproxen 
 Sulindac 
 Meloxicam 
4.6 MODEL USED FOR EVALUATING INFLAMMATIOn 
 Present day anti-inflammatory drug discovery is based on 
preliminary in vitro observations in a number of standard anti-
inflammatory assays, in which the test compound produces unushally 
potent antagonism of inflammatory pathways such as the arachidonic acid 
pathways and some cytokine cascades. The effective candidate drug in 
invitro test is later tested in whole animal models of acute, subacute and 
chronic inflammation.
(33) 
 Carrageenan induced paw edema model 
 Cotton pellet induced granuloma 
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PLANT PROFILE 
  LUFFA ACUTANGULA 
 
 
Figure 3: luffa acultagula leaf  
 
Biological Name  :  Luffa acutangula
 
Family                  :  cucurbitaceae
 
 
Vernacular name   
         Hindi           : kali.
 
         Tamil           : pirkankai. 
         Malayalam  : pichenga. 
         Telugu          : birakaya.
 
 
Plant Description 
        Colour        : light green with brownish yellow. 
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       Shape          : somewhat twisted,wrinkled and angular, single                                      
layered epidermis, covered by thick cuticle; 
secondary cortex is wide in each ridge, 
         Size             : petiole 3-8 cm long 
 
Growth and Distribution 
Luffa acutagula (L).Roxb. is a large monoeious annual climber. 
It
 is 
indigenous to western, central and southern regions of india, and regarded 
as wild variety of cultivated species. It  has smaller leaves, flower, fruits 
and seeds. A large climber with palmately 5-7 angled or lobed leaves 
found wild in northwest india, bihar, bengal, sikkim and assam, and also 
in madras. seeds much compressed, 10-12 mm. Long, slightly corrugated 
on edges, black when rip. Mostly its culivated in a warm-season, cold –
sensitive genus orginating in india.  Propagation of Luffa acutangula (L.) 
Roxb. by seeds. Luffa acutangula (L.) Roxb. can grow in all type of soils 
and can be grown in rainy Season. Seeds can accordingly be down either 
in February- marth (or) june- July.  Luffa is grown mostly as a novelty in 
florida grdens. However, some have been tried commertially for the sale 
of the sponges. Being cold sensitive, luffas should be grown during the 
warm season.    
Chemical constituents  
The reported chemical examination of  Luffa acultangula (L.) Roxb. 
showed the     Presence carbohydrates, carotene, fat, protein, phytin, 
aminoacid, alanine, arginine, cystine, glutamicacid, 
glycine,hydroxyproline, leucine, serine, tryptophan,pipecolic acid. And 
also presence of alkaloids, carotenoidsm and terpenoid, flavonoids, tannins, 
luffangulin, sapogenin, oleanolic acid, cucurbetacin B,E and 
anthraquinones. Leaves are a healthy food and contains good amount of 
fiber,differents types of vitamins such as Vitamin B2, Vitamin C, Calcium, 
phosphorus,iron and small quantities of iodine and fluorine. Seeds shows 
presence of saturated and unsaturated fatty acid palmatic, stearic, oleic, 
linoleic and traces of lignoceric acid. Plant shows presence of oleanane 
type triterpene saponins- acutoside A, B, C, D, E, F, and G.    
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Medicinal uses          
Luffa acutangula (L.) Roxb.is the source of many therapeutically 
important chemical constituents. Studies releaved its use in diabetes, 
immunomodulation, tumor suppresion, parkinsonism, antimocrobial, 
ulcer and hepatoprotection. And used as antioxidant, antipyretic, 
antiproliferative, anticataleptic, antimicrobial, analgesic and anti 
inflammatory agents.
 
 
 
  
 
 
 
 
 
 
 
 
LITERATURE REVIEW  
                                                                                   REVIEW OF LITERATURE 
 
Department of Pharmacology Page 24 
 
                                REVIEW OF LITERATURE  
A review of revealed literature is an essential aspects of scientific 
research. It involves the systemic identification, scrutiny and summaru of 
written material taht contains information on a research problem. It 
broadens the understanding and gain an insight of broad conceptual 
concept into which the problem fits. 
 
W. Kanwal et al., 2013
(34) 
 
Ethanol extract of Luffa cylindrica (L.) Roem. Fruit peel was 
evaluated for antiemetic and anti-inflammatory effect using chick emesis 
model and carrageenan induced rat paw edema. The antiemetic effect was 
observed at a dose of 150 mg /kg body weight whereas anti-inflammatory 
effect was observed at doses of 500, 750 and 1000 mg /kg body weight 
orally. Chlorpromazine 150mg/kg and indomethacin 10mg/kg orally were 
used as standard anti-emetic and anti-inflammatory drugs. The anti-
emetic effect was determined by calculating the mean decrease in number 
of retching in contrast with those of control after 10 minutes of copper 
sulfate (50mg/kg orally) administration. The degree of paw edema of all 
the groups was measured using a plethysmometer at 5th hour of 
carrageenan (1% w/v) administration. The extract exhibited statistically 
significant anti-emetic (P< 0.001) and anti-inflammatory (P< 0.05) 
effects. 
 
 Jusal et al., 2008
(35) 
 
The analgesic and hypoglycemic activities of Bixa orellana, 
Kyllinga monocephala, and Luffa acutangula were evaluated. Methanol 
extracts of B. orellana and L. acutangula showed significant 
hypoglycemic activities when administered 15 min after glucose load 
using a modified oral glucose tolerance test with Swiss Webster mice as 
test animals. An infusion of B. orellana was found to lower blood glucose 
level when administered 45 min before glucose load, while that of K. 
monocephala was found to lower blood glucose level when administered 
15 min after glucose load. The methanol extract of K. monocephala was 
found to significantly reduce the number of writhes in mice administered 
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intraperitoneally with acetic acid to induce abdominal constriction, while 
those of B. orellana and L. acutangula did not. 
 
 
Nipun Dashora et al., 2013
(36) 
 
Nature has been a source of medicinal agents for thousands of 
years, herbal medicines which formed the basis of health care throughout 
the world since the earliest days of mankind are still widely used. Luffa 
acutangula is widely growing vegetative climber and is used traditionally 
in folklore medicines for ailments including jaundice, diabetes, liver 
diseases, skin diseases, wounds etc. Taking into consideration, its 
medicinal importance and taxonomic confusion, exhaustive study of the 
morphology, tissue culture, phytochemical constituents, ethnobotany and 
biological activities of Luffa acutangula var. amara Roxb. fruits is 
carried out which will provide useful information in regard to its correct 
identity and help to differentiate from the closely related other species of 
Luffa.  
 
 
Ulaganathan Iyyamperumal et al., 2013
(37) 
 
The aim of the present study was to evaluate the anti-inflammatory 
effect and in vitro antioxidant potential of ethyl acetate (EAELA) and 
ethanol (EELA) extracts of dried leaves of Luffa acutangula (var) amara. 
Anti inflammatory effect was evaluated by carrageenan induced hind paw 
edema and cotton pellet granuloma models. Anti oxidant effect was 
evaluated applying in-vitro models were the free radical scavenging 
activity was measured. Both extracts at both dose levels were found to 
possess significant anti-inflammatory effect in acute and chronic models. 
The EELA and EAELA extracts at 25 to 800 mcg/ml concentrations 
showed significant anti-oxidant effect in Nitric Oxide and DPPH models. 
Reactive oxygen species scavenging and lipid peroxidation inhibition 
activities indicate that Luffa acutangula might be valuable natural 
antioxidant source. 
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Manikandaselvi et al., 2016
(38) 
 
Luffa acutangula L. (Common name: Ridge gourd, Family: 
Cucurbitaceae) is a popular vegetable in India and other Asian countries. 
It is a healthy food and contains good amount of fiber, vitamins and 
minerals including Vitamin B2, Vitamin C, carotene, niacin, calcium, 
phosphorus, iron and small quantities of iodine and fluorine. L. 
acutangula has been used extensively in Indian traditional system of 
medicines as diuretic, expectorant, laxative, purgative, hypoglycemic 
agent and bitter tonic. Various biological activities of this plant were 
reported including its use in weight loss, jaundice, blood purification, 
hypoglycemia, and constipation, skin care, and immune system booster, 
wound healing, eye problems, stomach worms and asthma. The present 
review work focused on its distribution, botanical characters, 
ethnobotanical uses, folklore claims, nutritional value, phytochemical 
constituents, medicinal properties and biological properties of L. 
acutangula. 
 
Kalaskar Mohan G et al., 2010
(39) 
 
The Luffa acutangula Linn. Var. amara Roxb. Is medicinal climber 
found in western, central and southern India, the fruits used in vata, kapha 
anemia, asthma, leucoderma, tumors, also useful as diuretic and in splenic 
enlargement. Scientifically it is proved as CNS depressant. The present 
study on pharmacognostical characters of Luffa acutangula var. amara 
Roxb. Fruits will be providing useful information in regard to its correct 
identity and help to differentiate from the closely related other species of 
Luffa and varieties Luffa acutangula. 
 
Dashora N et al., 2015
(40) 
 
The objective of the present study is to explore the anticancer 
activity of the ethanolic and aqueous extracts of the Luffa acutangula in 
Swiss albino mice against Ehrlich Ascites Carcinoma (EAC) cell line. 
Anticancer activity of ethanolic and aqueous extracts of Luffa acutangula 
was evaluated in EAC Swiss albino mice at the doses of 200 and 400 
mg/kg body weight orally. Ethanolic and aqueous extracts showed 
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significant decrease in (p<0.0001) tumor volume, viable cell count, tumor 
weight and elevated the life span of EAC tumor bearing mice. 
Haematological profiles such as red blood cell (RBC), haemoglobin, and 
white blood cell (WBC) count reverted to normal level in treated mice. 
The results demonstrated that the extract has potent dose dependent 
anticancer activity comparable to that of cisplatin. Aqueous extract at 
both doses (200 and 400 mg/kg) and ethanolic extract at 400 mg/kg dose 
showed potent anticancer activity 
 
W. Kanwal et al., 2013
(41) 
 
Ethanol extract of Luffa cylindrica (L.) Roem. Fruit peel was 
evaluated for antiemetic and anti-inflammatory effect using chick emesis 
model and carrageenan induced rat paw edema. The antiemetic effect was 
observed at a dose of 150 mg /kg body weight whereas anti-inflammatory 
effect was observed at doses of 500, 750 and 1000 mg /kg body weight 
orally. Chlorpromazine 150mg/kg and indomethacin 10mg/kg orally were 
used as standard anti-emetic anti-inflammatory drugs. The anti-emetic 
effect was determined by calculating the mean decrease in number 
ofretching in contrast with those of control after 10 minutes of copper 
sulfate (50mg/kg orally) administration. The degree of paw edema of all 
the groups was measured using a plethysmometer at 5th hour of 
carrageenan (1% w/v) administration. The extract exhibited statistically 
significant anti-emetic (P< 0.001) and anti-inflammatory (P< 0.05) 
effects. 
 
A. V. Misar et al.,2004
(42) 
 
The fruits of Luffa acultangula Var. amara C.B. C Clarke were 
collected in winter season from western ghat area. These fruit were dried, 
powdered, defatted with ethanol. HPTLC pattern of ethanol extract was 
recorded after removal of solvent and was studied for effect on 
behavioural changes, exploratory activity, barbiturates sleeping time, 
using appropriate standards im mice. The extract exhibited dose-
dependent CNS depressant activity. 
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Sanjay Kumar et al., 2013
(43)
  
Neem(azadiachta indica), popularly know as 'wonder tree' is an 
evergreentropical tree, which has been reported to have beneficial effects 
on various disease pathology from the ancient time. Such. Among all 
ingredient azadirachtin, nimbidin, flavonoids, triterpinoids are not able 
for their beneficial effect aganist disease pathology. Neem has reported to 
have anti-allergenic, anti-dermatic, anti-feedent, anti-fungal, anti-
inflammatory, anti-pyorrhoeic, anti-scabic mode of actions. 
Experimentalm observation releaved that NLE have analgesic, anti-
inflammatory and antipyretic effect in albino rats. 
 
Sumanta Mondal et al., 2009
(44) 
The methanol extract of Neolamarckia cadamba (family: 
Rubiaceae) barks significant analgesic, anti-infalmmatory and antipyretic 
activity. The acute toxicity, orally evaluated in mice, was found to be 
higher than 3000 mg/kg. The anti -inflammatory activity using 
carrageenan and antipyretic activity in yeast-induced pyrexia in rats. 
Were also examined. The extract at the dose 400 and 600 mg/kg 
significantly reduced the numbers of writhings at all tested doses 
(200,400 and 600 mg/kg p.o) The percentage inhibition of edema due to 
injection of carrageenan was found to be in promising result with 200 
mg/kg dose level. Although these result provide a support for the 
traditional uses of N.cadamba barks, further studies are nessessary to 
better evaluate its safety and mode of action. 
  
Shahbaa et al., 2015
(45) 
 
The aqueous extract of Parsley (Petroselinum crispum) were 
investigated for anti-inflammatory, analgesic and antipyretic activity at 
the doses of 2 , 5  and 10 g/kg of body weight. The experimental 
paradigms used were carrageenan, dextran, histamine induced pedal 
edema and cotton pellet induced granuloma for anti-inflammatory 
activity, while hot plate and acetic acid induced writhing methods were 
used to assess analgesic activity. Yeast-induced hyperpyrexia was used to 
evaluate the antipyretic activity. The extract also produced significant    
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(P < 0.01) analgesic activity in both paradigms. In addition, the aqueous 
extract of parsley potentiated the morphine and aspirin induced analgesia. 
A significant (P < 0.01) reduction in hyperpyrexia in rat was also 
produced by the extract. This study exhibits that methanol extracts of 
leaves of parsley possess anti-inflammatory, analgesic and antipyretic 
activities. 
  
Saba et al., 2011
(46) 
 
Ethanolic extract of the leaf of Calotropis procera was investigated 
for its anti-inflammatory and analgesic activities. The extract was 
evaluated using formalin-induced paw lick, carragenaan-induced paw 
oedema in Wistar rats, acetic acid-induced writhing and tail flick tests in 
mice. Each experiment consisted of thirty animals randomly, The 
administration of the extract was repeated for formalin-induced paw lick 
and acetic-acid induced writhing models in the presence of an opioid 
antagonist, naloxone. Inhibition of formation of paw oedema by the 
extract (100mg/kg b.w) was significantly higher than for Indomethacin. 
Itching was significantly reduced in rats administered with extract in the 
early phase of formalin response, and was comparable to Indomethacin 
(10mg/kg b.w). 100 mg/kg body weight of the extract also inhibited the 
writhing movement comparably with aspirin (15mg/kg b.w). Same 
pattern was also observed with tail flick model in mice 
 
Onasanwo et al., 2012
(47) 
Anacardium occidentalis (family: Anacardiaceae) is a plant of the 
tropical climate widely used by folklore to treat pain and inflammation. 
This study was conducted to evaluate the analgesic and anti-inflammatory 
effects of the leaf extracts in rat and mice using different models. The 
extract prolonged the latencies of tail withdrawal to a similar degree as 
pentazocine. The extract caused significant inhibition of carrageenan 
induced paw oedema in rats (P < 0.05) in a dose dependent manner.  
Phytochemical analysis showed that the leaf extracts contain alkaloids, 
tannins, saponins and cardenolides. 
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Safari et al., 2016
(48) 
 
Aloe volkensii has been used to manage several diseases including 
pain, inflammation and fever. The aim of this study therefore is to 
investigate the analgesic, antipyretic and anti-inflammatory activities of 
its aqueous extracts. Analgesic activity was determined by use of 0.05 ml 
of 2.5% formalin−induced writhing test. A writhe was recorded by a 
stopwatch. Anti-inflammatory activity was established by a formalin 
induced inflammation test. Hourly changes in paw sizes and reduction of 
edema around the paw was determined using a vernier calipers. 
Antipyretic activity was carried out using 0.03 g of 10 ml/kg of 15% w/v 
Brewer’s yeast-induced pyrexia. Temperature of each mouse was 
determined rectally by thermal probe thermometer. The results support 
the traditional use of A. volkensii in the treatment of various diseases 
associated with pain, fever and inflammation 
 
Neeraj Kumar Saini et al., 2012
(49) 
To evaluate the analgesic, anti-inflammatory and antipyretic 
activity of methanolic Tecomaria capensis (T. capensis) leaves extract 
using different models in rats. Methanolic T. capensis leaves extract (100, 
300, 1000 and 2000 mg/kg body weight) orally to observe acute toxicity, 
and observed for 14 days. Analgesic activity was evaluated using tail 
immersion and formalin induced paw licking models in rats. Anti- 
inflammatory activity was evaluated using carrageenan induced paw 
edema model in rat. Anti-pyretic activity was evaluated by using brewer's 
yeast induced by pyrexia model in rats. Results demonstrated that the no 
mortality was reported even after 14 days, this indicated that the methanol 
extract was safe up to a single dose of 2000 mg/kg body weight. This 
study   
 
Khadem Ali et al., 2012
(50) 
 
To explore the efficacy of ethanolic leaf extract of Typhonium 
trilobatum L. Schott in treating diarrhea, pain and inflammation using 
experimental models. In the present study, acetic acid-induced writhing, 
xylene-induced ear edema and castor oil-induced diarrheal model were 
used to evaluate the analgesic, anti-inflammatory and anti-diarrheal 
activities, respectively. In anti-diarrheal test, the extract significantly 
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decreased the frequency of defecation and increased the mean latent 
period (P<0.01) in castor oil-induced diarrheal model mice at the doses of 
250 and 500 mg/kg body weight. These results suggest that the extract 
possesses significant analgesic, anti-inflammatory and anti-diarrheal 
activities that support to the ethnopharmacological uses of this plant. 
 
Jude E Okokon et al., 2010
(51) 
 
The ethanolic root extract of C. zambesicus (27-81mg/kg) was 
evaluated for anti-inflammatory, analgesic and antipyretic properties in 
mice. The extract (27-81mg/kg) demonstrated a weak anti-inflammatory 
activity. However, asignificant (P<0.01-0.001) analgesic and antipyretic 
activities were observed in all the experimental models tested. The extract 
may be exerting its effects through central mechanisms. This finding 
confirms its ethnomedical use in the treatment of malarial-associated 
symptoms. 
  
Nwafor Paul A et al., 2010
(52) 
 
The effect of ethanolic extract of Smilax krausiana (Smilaceae) 
leaf was investigated for its analgesic and anti-inflammatory activities in 
mice. It also reduced in dose-related manner inflammation induced by 
fresh egg albumin, carrageenin and capsaicin. These inhibitions were 
statistically significant (p<0.01 – 0.001). Though the mechanism of 
action of the extract is not fully elucidated, it may in part involve 
suppression of capillary permeability through neurogenic and non-
neurogenic pathways as well as its narcotic potential. The extract’s 
inhibition of all the models investigated in a non-specific manner 
supports the folkloric use of the plant 
 
 
 Bokanisereme et al., 2013(53) 
 
The objective of this study was to evaluate the in-vivo anti-
inflammatory, anti - pyretic, analgesic activities and phytochemical 
analysis of ethanol cassava leaf extract (ECLE). The leaf extract was 
prepared with ethanol filter and rotary evaporated and stored in 
desiccator. A different concentration (100,250,500mg/kg) of the leaf 
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extract was evaluated for their anti-inflammary, analgesic and anti-pyretic 
effect using carrageenan and histamine induced oedema, acetic acid 
induced writhing and yeast induced pyrexia in rats respectively. The 
extract at concentration100, 250,500mg/kg was able to inhibit 
carrageenan and histamine induced oedema, acetic acid induced writhing 
and yeast induced pyrexia in rats. Terpernoids, tannins, flavonoids, 
carotenoids were found present in the ECLE. 
 
 
Safari VZ et al., 2016
(54) 
 
Acacia nilotica has been used to manage several diseases including 
pain, inflammation and fever. However, its efficacy has not been 
scientifically validated. The aim of this study therefore is to investigate 
the antinociceptive, antipyretic and anti-inflammatory activities of its 
aqueous extracts.  Antinociceptive activity was determined by use of 
formalin−induced writhing test. A writhe was recorded by a stopwatch. 
Anti-inflammatory activity was established by a formalin induced 
inflammation test. Hourly changes in paw sizes and reduction of edema 
around the paw was determined using a venier calipers. Antipyretic 
activity was carried out using Brewer’s yeast induced pyrexia. Anti-
inflammatory and antipyretic potential of aqueous leaf extracts of A. 
nilotica in albino mice and will serve as good bio-resource for generating 
readily available herbal formulations that are more effective in the 
treatment of pain, Inflammation and fever conditions which are cheaper 
than the conventional synthetic drugs and have no side effects. 
 
Sumanta Mondal et al., 2016
(55) 
 
Macrothelypteris torresiana is a species of fern native to tropical 
and subtropical region and belonging to family Thelypteridaceae. The 
present study was conducted to evaluate antipyretic, analgesic and anti-
inflammatory activities of ethanol extract from Macrothelypteris 
torresiana aerial parts (EEMTAP) at doses of 200 and 400 mg/kg body 
weight, per os. Analgesic activity was evaluated against both thermal and 
chemical induced stimuli, which were evidenced from tail immersion, 
formalin induced paw licking and acetic acid induced writhing test. 
Antipyretic activity was performed by using the yeast induced hyper-
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pyrexia method. Carrageenan induced rat paw edema and the cotton 
pellet granuloma model were selected for evaluating anti-inflammatory 
activities. EEMTAP also significantly decreased the rectal temperature of 
the rats. An ethanolic extract of Macrothelypteris torresiana possesses 
analgesic, anti-inflammatory and antipyretic activity which may be medi-
ated by the central and peripheral mechanisms. 
 
Alphonsine Ramde-Tiendrebeogo et al., 2015
(56)
  
 
            This study has been carried out to evaluate the in vivo anti-
inflammatory, analgesic and anti-pyretic effects of an aqueous decoction 
and ethanol extract (95%) of Ficus sycomorus leaves. The anti-
inflammatory effect was evaluated by the carrageenan-induced mice paw 
oedema model. The non-morphine type analgesic effect was evaluated 
trough acetic acid-induced writhing test. The morphine type analgesic 
activity was tested by mouse tail–flick test. The anti-pyretic activity was 
tested by induced hyperthermia in mice with brewer's yeast. At the same 
dose, the analgesic effect of the ethanol extract on abdominal writhings 
induced by acetic acid,  The antipyretic activity of the extracts at the same 
doses was comparable to those of the LAS (300 mg/ kg b.w.) and 
hydrocortisone (10 mg/kg b.w.) from the third hour.  
 
 
Bairagi Shripad et al., 2012
(57) 
 
              Ficus Microcarpa L. is a medicinal plant used for the treatment 
of various body pains in India traditionally. The methanol extract of its 
leaves was investigated for its analgesic and anti-inflammatory activities 
in animal models. The extract at 50, 100 and 200mg/kg body weight 
reduced significantly the formation of oedema induced by carrageenan 
and histamine. The extract had a good analgesic effect characterized by a 
reduction in the number of writhes when compared to the control. 
Similarly, the extract caused dose-dependent decrease of licking time and 
licking frequency in rats injected with 2.5% formalin. Acute toxicity test 
showed that the plant may be safe for the pharmacological uses. This 
study has provided some justification for the folkloric use of the plant in 
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several communities for conditions such as pain, skin allergies and 
inflammations. 
 
Omoniyi et al., 2017
(58) 
 
Aqueous root extract of Dalbergia saxatilis, Hook, f., 
(Leguminosae) (DS) is reported useful for toothache, pains, and fever, but 
not scientifically proven. This study determined its effectiveness in pain, 
inflammation, and fever, applying scientific models. The analgesic 
activity was measured by acetic acid writhing, tail flick, tail immersion, 
tail clip, hot plate, and formalin pain tests; anti-inflammatory effects were 
determined via carrageenan and dextran rat paw oedema tests; antipyretic 
activity was measured by Escherichia coli lipopolysaccharide (ECL) and 
turpentine in rabbits, and D-amphetamine sulphate (D-AS) pyrexia test in 
rats.Unlike morphine, DS did not produce significant prolongation of the 
reaction times in the hot-plate, tail immersion, tail flick, and tail clip tests. 
As well as significant antipyretic actions involving cyclooxygenase, a2 
adrenoceptor and interleukin-1 b1 due to any of glycosides, saponins or 
phenolic tannins. 
 
Godwin Christian Akuodor et al., 2016
(59) 
 
To investigate the the analgesic, anti-inflammatory and antipyretic 
activities of the methanolic leaf extract of Maerua crassifolia in mice and 
rats. Acetic acid-induced writhing and tail immersion methods were used 
to assess analgesic activity, while xylene and carrageenan-induced paw 
oedema methods were used to evaluate the anti-inflammatory effect of 
the leaf extract. Yeast and amphetamine-induced pyrexia were used to 
investigate the antipyretic activity.  The leaf extract (100, 200, and 400 
mg/kg) showed a dose dependent and significant (P < 0.05) inhibition of 
pain in acetic acid-induced writhing and tail immersion tests. The 
phytochemical screening revealed the presence of alkaloids, flavonoids, 
terpenoids, tannins, steroids, resins, saponins and cardiac glycosides. The 
oral median lethal dose of the leaf extract was estimated to be greater 
than 5000 mg/kg in rats. The findings confirmed its ethno medical use in 
the treatment of pains and feverish conditions. 
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Sourabie1 T S et al., 2012
(60) 
 
The present study deals with evaluation of the anti-inflammatory 
and analgesic properties of a lyophilized leaf extract of Argemone 
mexicana Linn. On laboratory animal. The anti-inflammatory study was 
done by using carrageenan-induced paw edema method. It was found that 
lyophilized extract can be effective in acute inflammatory disorders and 
in that case, it showed significant anti-inflammatory dose-dependent 
effect(p<0,001) at the dose level of 250 mg/kg and 500 mg/kg.The plant 
extract was equally tested for its analgesic potential by using the hot plate 
test method and acetic acid Writhing method. By the hot plate method, 
the drug extract showed significant (p<0,001) increased latency 
periodthan the control group at oral dose of 250 and 500 mg/kg. 
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OBJECTIVE AND PLAN OF THE WORK 
 
OBJE CTIVE OF THE WORK 
Non–steroidal anti-inflammatory drugs (NSAIDs) are used 
worldwide for their wide range of activity. However its side effects are 
high. Natural products from medicinal plants have more pharmacological 
significance with improved efficacy and lesser side effects 
Luffa acultagula (L.)Roxb. Is an Indian traditional medicine used 
for analgesic, anti-inflammatory activity. Hence the present work was 
aimed to explore the use of extract of Luffa acultagula (L.) Roxb. With 
proper validation.  
PLAN OF WORK 
 Literature survey. 
 Collection of plan material and its authentication. 
 Preparation of extract and preliminary phytochemical evaluation. 
 Approval of protocol by institutional animal ethical committe. 
constituted as per the direction of CPCSEA to conduct animal 
study. 
 Finding the dosage range of the extract as per OECD guidelines. 
 Pharmacological studies. 
       1.  Analgesic activity. 
 Hot plate method in mice. 
 Acetic acid induced writhing response in mice. 
 Tail immersion test. 
                   2.  Anti-Pyretic Activity. 
                   3.  Anti-inflammatory activity. 
 Carrageenan –induced paw edema in rats. 
 Cotton pettel induced granuloma method in rats. 
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                              MATERIALS AND METHODS 
 
PLANT COLLECTION AND AUTHENTIFICATION 
Plant collection 
Luffa acutangula plant was collected in and erodes in the month 
march 2017 
Authentification 
The plant was identified by Dr. C. Murugn, Scientist 'D' and Head 
of  office, Botanical  survey  of  India, Tamil Nadu  Agricultural 
University Campus, and Coimbatore bearing the reference number 
BSI/SRC/5/23/2017/Tech/691. 
Drying and Pulverization of the plant material 
After collection and authentification the leaves were washed to 
remove the dust Particles and allowed to air dry in a shade for complete 
drying. Then the dried leaves without moisture were powdered in a mixer 
grinder. 
Preparation of the plant extract 
The coarse powder was packed tightly in the soxhlet apparatus and 
extracted with ethanol for 72 hours with occasional shacking maintained at 
60ºc throughtout the extraction process. The extract was concentrated to of 
its original volume by evaporation. The resulting ethanolic extract of the 
Luffa acutangula (L.) Roxb. was subjected to phytochemical study. 
Phytochemical analysis  
The ethanolic extract of Luffa acutangula (L.) Roxb. were 
subjected to qualitative phytochemical tests for different constituents such 
as alkaloids, carbohydrates, glycosides, flavonoids, phenolic compounds, 
proteins, and free aminoacids and triterpenoids. 
1. Test for carbohydrate 
Small quantity of extract was dissolved in 5ml of water and 
filtered. 
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Molisch test 
The filtrate was treated with a few drops of α- napthol (20% in 
ethyl alcohol). Then 1 ml of concentrated H2SO4 was added along the sides 
of inclined test tube and observed for formation of violet coloured ring at 
the interface.
(61) 
2. Test for glycosides and anthroquinones 
Borntrager’s test 
A small amount of ethanolic extract was hydrolysed with 
hydrochloric acid for few hours on water bath and the hydrosylate was 
extracted with benzene. The benzene layer was treated with dilute 
ammonia solution and observed for the formation of reddish pink colour. 
Legal test 
The extract was dissolved in pyridine and made alkaline with few 
drops of 10% NaOH and freshly prepared sodium nitroprusside was added 
and observed for formation of blue colour. 
3. Test for flavonoids 
Ammonia test 
Filter paper strips were dipped in the dilute solution of the extract, 
ammoniated and observed for colour change from white to yellow.
(62) 
4. Test for Tannins and Phenolic compounds 
The extract was dissolved in distilled water and dissolved into 
three portions. Sodium chloride (10%) was added to one portion, 1% 
gelatine to second portion and gelatine salt reagent to third portion. 
Precipitation with later or both gelatin salt reagents was indicative of the 
presence of tannins. Precipitation with salt solution indicates a false 
positive test. Positive tests were further confirmed by the addition of a few 
drops of dilute ferric chloride (1%FeCl3) to the test extract which gave 
blue or green black coloration.  
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5. Test for Proteins and Aminoacids 
Small amount of extract was dissolved in distilled water and 
filtered. 
Biuret’s test 
To the ammoniated alkaline filtrate add 2-3 drops of 0.002% 
copper sulphate and observed for appearance of red or violet colour. 
Millon’s test 
To 2 ml of filtrate 5-6 drops of millons reagent (1 g of mercury + 9 
ml of fuming nitric acid solution) was added and observed for red 
precipitates. 
Ninhydrin test 
To the filtrate lead acetate solution was added to precipitate tannins 
and filtered. The filtrate was spotted on paper chromatogram and sprayed 
with ninhydrin reagent and heated at 110ºC for five minutes and observed 
for red or violet colour. 
Xanthoprotein test 
To the filtrate a few drops concentrated nitric acid was added by 
the side of test tube and observed for appearance of yellow colour. 
6. Test for sterols and triterpenes 
The extract was refluxed with alcoholic potassium hydroxide until 
the completion of saponification. Then the mixture was diluted with 
distilled water and extracted with diethyl ether. The ethereal extract was 
evaporated and the unsaponifiable matter was subjected to the following 
tests. 
Libermann- Buchard’s test 
The ether soluble residue was dissolved in chloroform and a few 
drops of acetic anhydride was added followed by a few drops concentrated 
sulphuric acid form sides of the test tube and observed for the formation of 
blue to blue- red colour. 
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Salkowski’s reaction 
To the ether soluble residue 2 ml of concentrated sulphuric acid 
was added and observed for the formation of yellow ring at the junction 
which turns red after one minute. 
Animal approval  
The study was conducted after obtaining from committee for the 
purpose of control and  supervision on animals (CPCSEA) and  
institutional animal ethics committee (IAEC), proposal number 
NCP/IAEC/NO:02/2016-17 
Animals 
Swiss albino mice weighing 20-25 gm wistar rats weighing 150-
200 gm were used for this study. The animals were obtained from animal 
house, Nandha College pharmacy, Erode, Tamilnadu, India. On arrival, the 
animals were placed randomly and allocated to treatment groups in 
polypropylene cages with paddy husk as bedding. Animals were housed at 
a temperature of 24±2ºc and relative humidity of 30-70%. A12: 12 light: 
day cycle was followed. All animals were allowed to free access to water 
and bed with standard commercial pelleted chow. All the experimental 
procedures are protocols used in this study were reviewed by Institutional 
Animal Ethics Committe (688/02/C-CPCSEA) of Nandha college of 
pharmacy, proposal number (NCP/IAEC/NO: 2016-2017) and were 
accordance with the guidelines of the IACE 
Acute Toxicity Studies 
           The acute toxicity was performed according to OECD guidelines 
423. The selected albino rats were used for toxicity studies. The animals 
were divided into five groups of three in each. The animals were fasted 
overnight prior to the acute experimental procedure. Extract was given 
orally to rats at the graded doses like 5, 50, 100, 1000 & 2000 mg/ kg body 
weight. Immediately, after dosing, the animals were observed continuously 
for first four hours for behavioural changes were closely observed for 
hyperactivity, ataxia, convulsion, salivation, tremors, diarrhoea, lethargy, 
sleep. They were then kept under observation up to 14 days after drug 
administration to determine the mortality, if any. One-tenth and one-fifth 
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of the maximum tolerated dose (200 and 400 mg/ kg, body weight) of 
ethanol leaf extract of Luffa acutangula((L) Roxb. selected to evaluate 
analgesic, anti-inflammatory and antipyretic activity studies in rats
(49)
. 
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                        PHARMACOLOGICAL STUDIES 
 
ANALGESIC ACTIVITY 
 
HOT PLATE METHOD IN MICE 
        The hot plate assay method was employed for the purpose of 
preferential assessment of possible centrally medicated analgesic effects of 
ethanolic extract of Luffa acutangula (L.) Roxb.The central analgesic drug 
pentazocine was used for positive control group. In this experiment, four 
groups (n=6) of Swiss albino mice (20-25 g) were placed on a hot plate 
maintained at room temperature for 15 min. Food was withdrawn on the 
preceding night of the experiment. Group I- Normal Control received 
CMC (0.5%), and Group II- standard treated with pentazocine (3 mg/kg 
i.p), whereas group III and IV- animals were treated orally with ethanolic 
extract of Luffa acutangula (L.) Roxb. (200 and 400 mg/kg respectively). 
 
Group I      :  Normal control (CMC) 
Group II     : Standard (Pentazocine 3 mg/kg) 
Group III    : Test Drug I (Ethanolic leaf extract of Luffa acutangula) 
Group IV    : Test Drug II (Ethanolic leaf extract of Luffa 
acutangula) 
 
         Each animal was then individually placed gently on Eddy's hot plate 
at 55ºC. Latency to exhibit nociceptive responses such as licking paws or 
jumping off the hot plate were determined at 30, 60, 90 and 120 min after 
administration of the drugs or vehicle
(43)
. 
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TAIL IMMERSION TEST 
 This method assessment was used to evaluate the centrally 
medicated analgesic effects of ethanolic extract of Luffa acutangula (L) 
Roxb. The wistar rats were divided into four groups each consists of six 
animals. They were placed into individual restraining cages leaving the tail 
hanging out freely. The lower 5cm portion of the tail is marked and this 
part of the tail was immersed in a water bath containing water at a 
temperature of 55± 0.5 ºC.  Withdrawing the tail from the hot water 
showed the analgesic effect. The reaction time was noted on a stop-watch. 
Each animal served as control. The average of the two values was the 
initial reaction time. Group –II served as standard and received 
pentazocine (3 mg/kg, i.p) The Group III and IV were treated orally with 
ethanolic extract of Luffa acutangula (L.) Roxb. (200 mg/kg and 
400mg/kg) respectively,  
 
Group I        :  Normal Control  
Group II       : Pentazocine (3 mg/kg) 
Group III      : Test Drug I (Ethanolic extract leaf Luffa acutnagula) 
Group IV      : Test Drug II (Ethanolic extract leaf Luffa acutangula) 
 
The reaction time of the groups were taken at 0, 30, 60, 90 and 
120min. The cut off time of the immersion was 15seconds. The reaction 
time was measured. 
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ACETIC ACID INDUCED WRITHING RESPONSE IN MICE 
        This method was used to preferentially evaluate possible peripheral 
analgesic effects of ethanolic extract of Luffa acutangula (L.) Roxb. Four 
groups of Swiss albino male mice (n=6) were fasted overnight prior to start 
the experiment with free access to water. The peripheral analgesic drug 
Diclofenac sodium (10 mg/kg) was used as a positive control. Group-I 
Normal Control received CMC (0.5%) Group-II was treated with 
Diclofenac Sodium (10mg/kg), whereas Group III and IV were treated 
orally with the ethanolic extract of Luffa acutangula (L.) Roxb. at a dose of 
200 mg/kg and 400mg/kg respectively. 
 
Group I        :  Normal Control  
Group II       : Diclofenac Sodium (10mg/kg) 
Group III      : Test Drug I (Ethanolic extract leaf Luffa 
acutangula) 
Group IV      : Test Drug II (Ethanolic extract leaf Luffa 
acutangula) 
 
 After 30 min of treatment, the mice were injected intra 
peritoneally with 0.1 ml of 1% acetic acid solution to induce the 
characteristic writhings. The mice were then placed in an observation box 
and the numbers of writhing were counted in a 5min period. The response 
of the extract and Diclofenac sodium treated groups was compared with 
those of animals in the control group
 (44)
. 
 
 
 
 
 
 
                                                            MATERIALS AND METHODS 
 
Department of pharmacology Page 45 
 
ANTI-PYRETIC ACTIVITY 
The estimation of anti-pyretic efficacy of ethanolic extract was 
carried out using brewer's yeast induced pyrexia method. Fever was 
induced by means of subcutaneously injecting 10.0 ml/kg of a 20% w/v 
suspension of brewer's yeast in normal saline. Only animals whose rectal 
increased by at least 1.0º C after subcutaneously injecting 10.0 ml/kg of a 
20%w/v suspension of brewer's yeast in normal saline. Only animals 
whose rectal temperature increased by at least 1.0ºC after 18 h of this yeast 
injection were included for the study. The normal rectal temperature of 
each animal was measured by using a flexible tail thermostat probe coated 
with lubricant, and temperature was recorded using a digital 
telethermometer. The experimental animals were randomly divided into 
four groups containing six animals in each group. The control group (I) 
was orally administered 0.5ml saline while the standard group (II) was 
given 150 mg/kg paracetamol and groups III and IV were prescribed dose I 
and II of methanol extract of test drugs, respectively
 (43)
. 
 
Group I        :  Normal Control (CMC) 
Group II       : Paracetamol (150mg/kg) 
Group III      : Test Drug I (Ethanolic extract leaf Luffa acultangula) 
Group IV      : Test Drug II (Ethanolic extract leaf Luffa acultangula) 
 
The rectal temperature was recorded at time intervals of 1, 2, 3and 
4 h after drug administration. Animals are rehabilitated with standards 
anti-pyretic drugs. 
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ANTI-INFLAMMATORY ACTIVITY 
CARRAGEENAN-INDUCED PAW EDEMA IN RATS 
For this experiment, the rats (120-150g) were divided into four 
groups (n=6). The group I received 0.5% CMC (10ml/kg), while the Group 
II received Indomethacin (10mg/kg). The Group III and IV were treated 
orally with the ethanolic extract of Luffa acutangula (L.) Roxb. at a dose of 
200 mg/kg and 400 mg/kg orally.  
 
Group I        :  Normal Control (CMC) 
Group II       : Indomethacin (10mg/kg) 
Group III      : Test Drug I (Ethanolic extract leaf Luffa acutanula) 
Group IV      : Test Drug II (Ethanolic extract leaf Luffa acutangula) 
 
Acute inflammation was produced by injecting 0.1 ml of 1% (w/v) 
carrageenan suspension into the sub planter region of the right hind paw of 
the rats. The animals were pre treated with the drug 1hour before the 
administration of carrageenan
 (51)
.The paw thickness was measured at 1, 2, 
3 and 4 h after carrageenan injection by using digital vernier callipers. 
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COTTON PELLET INDUCED GRANULOMA METHOD IN RATS 
Cotton pellets, weighing 5mg each were sterilized. Under ether 
anaesthesia, the pellets were introduced subcutaneously through a skin 
incision on the back of the animals. Starting from 30 min after the 
implantation of cotton pellet for all the rats, Group-I normal control 
received CMC (0.5%) orally. Group-II was treated with Dexamethasone (1 
mg/kg), whereas Groups III and IV were treated orally with 200 mg/kg and 
400 mg/kg of ethanol extract of Luffa acultangula (L.) Roxb.
 (48)
. 
 
Group I        :  Normal Control (CMC) 
Group II       : Dexamethasone (1mg/kg) 
Group III      : Test Drug I (Ethanolic extract leaf Luffa acultangula) 
Group IV      : Test Drug II (Ethanolic extract leaf Luffa acultangula) 
 
The test drugs were administered daily for 7days. On the 8
th
 day, 
the animals were sacrificed with diethyl ether. The granulomas were 
removed and the weighed. 
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                                               RESULTS 
 
1. Qualitative phytochemical Evaluation of Luffa acultagula (L) 
Roxb. 
    Table 1 
 
                 Parameters  
 
                       value 
 
1. Alkaloid                                                                                   
 
2. Carbohydrates 
 
3. Glycosides 
 
4. Flavonoids 
 
5. Tannins & Phenolic compounds 
 
6. Proteins & Amino acids 
 
7. Saponins 
 
8. Sterols or Triterpenes 
 
 
+ 
 
                        + 
 
                        - 
 
                       ++ 
 
                        + 
 
                        + 
 
                        + 
 
                        +  
     ++: high content, +: moderate, - : Negative,   
 
From the qualitative phytochemical analysis of ethanolic extract of Luffa 
acultagula (L)Roxb.  It content alkaloids, Tannins, phenolic compound, 
sterols, saponins, protein and amino acids and high amount of flavonoids. 
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1. Analgesic activity 
Hot plate Method in Mice 
  The analgesic activity of ethanolic leaves extract of Luffa 
acutangula (L) Roxb. was assessed using hot plate method in Swiss 
albino mice. The ethanolic leaves extract of Luffa acutangula(L) Roxb. 
Showed significant analgesic activity at 200 and 400 mg/kg. Analgesic 
activity was comparable with standard drug pentazocine. Among the two 
doses, 400 mg/kg showed maximum analgesic activity at reaction time 
120 min (7.2±0.44) is slightly lower than the standard drug pentazocine 
(9.9±0.34) in this analgesic testing model, pentazocine significantly 
prolonged the reaction time of animals with relatively extended duration 
of stimulation, confirming centrally active drugs. In the present study, all 
extracts showed significant (p<0.05 and p< 0.01) analgesic activity but 
among the two doses, 400 mg/kg showed highest analgesic activity at 
reaction time120 min.   
                                                                                                                                                          
RESULTS 
 
Department of Pharmacology Page 50 
 
Table: 2 Analgesic effect of ethanolic extract of of Luffa acutangula (L) Roxb on hot 
plate test in Swiss albino mice 
 
             
              GROUP 
 
Paw licking or jumping in seconds 
 
30min 
 
                  
60min 
 
90min 
 
120min 
              Group-I 
              Control 2.2±0.22 2.6±0.12 2.9±0.21 2.8±0.10 
Group-II 
   Pentazocine(3 
mg/kg) 
2.8±0.18 6.9±0.62** 9.8±0.64** 9.9±0.34** 
              Group-
III 
           ( 
200mg/kg) 
2.7±0.20 3.7±0.15* 4.6±0.21** 4.1±0.41** 
Group-IV 
(400mg/kg) 2.8±0.14 5.8±0.37** 7.4±0.39** 
 
7.2±0.44** 
 
Values were mean ± SEM, (n=6), *P<0.05  **P<0.01 Vs control. 
 Data were analyzed by using One-way ANOVA followed by Dunnett’s test. 
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Graph 1: Analgesic effect of ethanolic leaves extract of of Luffa acutangula (L) Roxb 
on hot plate method in mice. 
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Tail Immersion Method 
 There was a significant reduction of pain full sensation due to tail 
immersion in warm water. The maximum inhibitory effect of Luffa 
acutangula (L) Roxb. Showed significant (p< 0.01) at 90 min post dose in 
400 mg/kg. The maximum anti- nociceptive properties of the plant extract 
(3.5±0.04) were not as effective as that of pentazocine, 3 mg/kg 
(5.8±0.06) 
 
 
 
 
Graphs 2:  Analgesic Effect Of Ethanolic Leaves Extract Of  Luffa Acutangula (L) 
Roxb On Tail Immersion Method In Rats. 
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Table: 3 Analgesic effect of ethanolic leaves extract of Luffa acutangula (L) 
Roxb on tail immersion method in rats 
Values were mean ± SEM,( n=6), *P<0.05  **P<0.01 Vs control. Data were analyzed by 
using One-way ANOVA followed by Dunnett’s test. 
 
       
              GROUP 
 
Mean latency to tail immersion in seconds 
      0 min       30min 
 
        60min 90min 120min 
Group-I 
Control 
 
1.5±0.04 
 
1.4±0.02 
 
1.6±0.01 
 
1.6±0.03 
 
1.7±0.04 
Group II 
Pentazocine(3mg/kg) 
 
1.8±0.06 
 
2.6±0.04** 
 
4.2±0.02** 
 
5.8±0.06** 
 
5.4±0.02** 
Group III 
(200mg/kg) 
 
1.2±0.02 
 
 
1.9±0.01* 
 
2.1±0.04* 
 
2.4±0.02 
 
2.8±0.04* 
Group IV 
(400mg/kg) 
 
1.4±0.01 
 
2.0±0.04* 
 
2.6±0.01** 
 
3.5±0.04** 
 
3.2±0.01** 
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Acetic Acid- Induced Writhing Response in Mice 
 The oral administration of ethanolic leaves extract of Luffa 
acutangula (L) Roxb. Showed a dose dependent analgesic activity.  
Injection of acetic acid into control mice produced 51.4±6.4 writhes. Pre-
treatment with ethanolic extract of Luffa acutangula (L.) Roxb. at doses 
of 200 and 400 mg/kg reduced the number of writhes 39.4±2.4 (23.34 % 
protection) and 31.2±2.1 (39.29 % protection) respectively. Among the 
two doses 200, 400 mg/kg showed the slightly lower analgesic activity 
than standard drug Diclofenac Sodium 22.8±1.9 (55.64 % protection) it 
was observed that the onset of writhing was delayed and duration of 
writhing was shortened. 
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Table: 4 Analgesic effects of ethanolic leaves extract of Luffa acutangula (L) Roxb, 
(on acetic acid writhing test in Swiss albino mice 
 
 
GROUP 
 
 
Number of writhes  
 
% Inhibition 
Group-I 
Control 
 
51.4±6.4 
 
___ 
Group-II 
Diclofenac Sodium 
(10mg/kg) 
 
 
22.8±1.9** 
 
 
55.64 
Group-III 
(200mg/kg) 
 
39.4±2.4** 
 
23.34 
Group-IV 
(400mg/kg) 
              
                         31.2±2.1** 
 
39.29 
 
Values were mean ± SEM, (n=6), **P<0.01 Vs control. Data were analyzed by using  
One-way ANOVA followed by Dunnett’s test. 
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Graph 3: Analgesic effect of ethanolic leaves extract of of Luffa acutangula (L) Roxb, 
on acetic acid induced writhing response in mice. 
 
 
Graph 4: Analgesic effect of ethanolic leaves extract of of Luffa acutangula (L) Roxb, 
on acetic acid induced writhing response in mice. Results are expressed as a 
percentage of inhibition. 
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2. Anti-pyretic activity 
 
Brewer's Yeast Induced Pyrexia in Rats 
The anti-pyretic activity of ethanol leaves extract of Luffa 
acutangula (L.) Roxb. against yeast induced pyrexia is shown in Table 6. 
The ethanolic leaves extract of Luffa cutangula (L.) Roxb. at a doses of 
200 and 400 mg/kg showed significant effect against Brewer’s yeast 
induced pyrexia method. There was a progressive dose dependent 
reduction in the temperature of rats treated with the extract. The reduction 
caused by the extract was significant when compared to control. 
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   Table: 7 Anti-Pyretic Activity Of Ethanolic Extract Of Luffa Acutangula (L) Roxb  On 
Brewer's Yeast Induced Pyrexia In Rats 
           Values were mean ± SEM, (n=6), **P<0.01 Vs control. Data were analyzed by using  
           One-way ANOVA followed by Dennett’s test. 
 
 
 
Treatment 
Rectal temperature (°C) 
18 h 
after 
yeast 
administ
ration 
Temperature after treatment 
 
1 h 
 
2 h 
 
3 h 
 
4 h 
Group-I 
Control 
 
38.1±0.1 
 
38.4±0.2 
 
38.0±0.1 
 
38.3±0.2 
 
38.2±0.1 
Group-II 
Negative 
control 
 
40.2±0.1
 
 
40.4±0.3
** 
 
 
 
40.1±0.2 
 
39.8±0.1 
 
39.1±0.3 
Group-III 
paracetamol 
 
39.8±0.2 
 
37.9±0.2 
 
38.2±0.2 
 
38.0±0.1 
 
38.4±0.2 
Group-IV 
 (200mg/kg) 
 
40.2±0.1 
 
39.4±0.3 
 
39.1±0.1 
 
39.0±0.2 
 
38.9±0.3 
Group-V 
(400mg/kg) 
 
40.1±0.1 
 
38.8±0.1 
 
38.5±0.2 
 
38.4±0.1 
 
38.5±0.2 
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Graph 9: Anti-Pyretic Activity of Ethanolic Leaves Extract of Luffa Acutangula (L) 
Roxb, On Brewer's Yeast Induced Pyrexia in Rats. 
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3. Anti-Inflammatory Activity 
Carrageenan-Inuced Paw Edema in Rats 
 The anti-inflammatory effect of the ethanolic leaves extract of 
Luffa cautangula (L.) Roxb on carrageenan – induced hind paw edema as 
shown in Table 4. The ethanolic leaves extract of Luffa acutangula (L.) 
Roxb. at doses 200 and 400 mg/kg produced a significant effect aganist 
carrageenan induced inflammatory effect . The dose of 400 mg/kg 
exhibited a significant inhibition of 48 % after 3 h, the effect increased 
after 3h (52%). Anti-inflammatory activity of ethanolic extract of Luffa 
cautangula (L.) Roxb. showed significant and similar to that of 
indomethacine (10 mg/kg).  
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Table: 5 Anti inflammatory activity of ethanolic extract of Luffa acutangula (L) 
Roxb on Carrageenan induced paw edema method in Wistar rays. 
 
          Values were mean ± SEM, (n=6), *P<0.05, **P<0.01 Vs control. Data were analyzed 
by using  One-way ANOVA followed by Dunnett’s test 
 
       
         
GROUP 
 
Paw thickness in mm 
 
% 
Inhibitio
n at 3hr  
 
0 hr 1hr 
 
 
2hr 3hr 4hr 
Group-I 
Carrageenan 
(control) 
 
1.4±0.03 
 
3.4±0.06 
 
        
4.9±0.06 
 
     
6.4±0.05 
 
      
4.8±0.02 
 
------ 
Group-II 
Indomethaci
n 
(10mg/kg) 
 
       
1.4±0.04 
 
      
2.2±0.03** 
 
      
2.9±0.04** 
 
     
3.1±0.02** 
 
    
2.2±0.04** 
 
52 
Group-III 
(200mg/kg) 
 
 
       
1.2±0.02 
 
      
3.0±0.04 
 
       
4.2±0.03 
 
      
4.7±0.01* 
 
    
3.5±0.04** 
 
27 
Group-IV 
(400mg/kg) 
 
      
1.1±0.01 
 
      
2.7±0.04** 
 
      
3.5±0.02* 
 
      
3.3±0.06** 
 
     
2.8±0.04** 
 
48 
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Graph 5: Anti-inflammatory activity of ethanolic leaves extract of Luffa acutangula 
(L) Roxb, on carrageenan induced paw edema method in Wistar rats. 
 
 
Graph 6: Anti-inflammatory activity of ethanolic leaves extract of Luffa acutangula 
(L) Roxb, on carrageenan induced paw edema method in Wistar rats. Results are 
expressed as a percentage inhibition. 
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Cotton Pellet-Induced Granuloma Method in Rats 
 The anti-inflammatory effect of the ethanolic leaves extract of 
Luffa acutangula (L.) Roxb. assessed by using cotton pellet induced 
granuloma method in Wistar rats. The ethanolic leaves extract of Luffa 
acutangula (L.) Roxb. Showed significant anti-inflammatory activity at 
200 and 400 mg/kg  dose. After 7 days, the mean weight of 
granulomatous tissue surrounding the threads was significantly lower for 
the group treated with Luffa acutangula (L.) Roxb. extract as compared to 
the control group. Among the two doses 400 mg/kg showed maximum 
decreased formation of granuloma tissue. The results indicate that Luffa 
acutangula (L.) roxb. at dose level of 200mg/kg and 400 mg/kg produced 
a significant decrease in the weight of  granuloma 38.16±0.04 (7.4% 
inhibition) and 34.58±0.04 (16.1% inhibition) respectively. Among the 
two dose 400 mg/kg showed the slightly lower reduced weight of 
granumola than standard drug dexamethazone 28.92±0.04 (29.8% 
inhibition) 
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Table.6 Anti inflammatory activity of ethanolic extract of Luffa acutangula (L) Roxbon  
cotton pellet induced granuloma pouch model Wistar rats 
 
  Values were mean ± SEM, (n=6), **P<0.01 Vs control. Data were analyzed by using  
   One-way ANOVA followed by Dennett’s test. 
 
 
GROUP 
 
       
     Granuloma weight (mg) 
 
 
           % Inhibition 
Group-I 
Control 
 
41.24±0.04 
 
___ 
Group-II 
Dexamethazone 
(1mg/kg) 
 
28.92±0.04** 
 
                    29.8 
Group-III 
200mg/kg 
 
38.16±0.04** 
 
7.4 
Group-IV 
400mg/kg 
 
34.58±0.04** 
 
16.1 
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Graph 7: anti-inflammatory activity of ethanolic leaves extract of Luffa acutangula 
(L) Roxb, on cotton pellet-induced granuloma in rats. 
 
 
Graph 8: anti-inflammatory activity of ethanolic leaves extract of Luffa acutangula 
(L) Roxb, on cotton pellet-induced granuloma in rats. Results are expressed as a 
percentage of inhibition. 
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                                               DISCUSSION  
 
              The inflammation is complex process, which is frequently 
associated with pain and involves several events, such as the increase of 
muscular permeability, increase of granulocytes and mono nuclear cell 
migration, as well as the granulomatous tissue proliferation.
(63)
 Pain is 
subjective experience, which is difficult to define exactly even though we 
all experience it. Pain distinguished as two types, peripheral or 
neurogenic pain may involve the following pathological states: peripheral 
nociceptive afferent neurons which are activated by noxious stimuli and 
central mechanism which is activated by different inputs pain sensation. 
             The hot plate model was selected to investigate central 
antinociceptive activity because it has several advantages particularly the 
sensitivity to strong antinociceptive and limited tissue damage. 
Prostaglandins and bradykinins were suggested to play an important role 
in pain. Phenolic compounds are reported to inhibits prostaglandin 
synthesis
(64)
.  A number of phenolic compounds have been reported to 
produce analgesic activity. Other studies have demonstrated that various 
flavanoids such as rutin, quercetin, luteolin, biflavonoids and 
triterpenoids produced significant antinociceptive effect. As 
phytochemical test showed presence of flavonoids and tannins in 
ethanolic extract of Luffa acutangula (L) Roxb, they might suppress the 
formation of prostaglandin and bradykinins. 
           Acetic acid is known to trigger the production of noxious 
substances within the peritoneum, which induces the writhing 
response
(65)
. The effect of the extract aganist the noxious stimulus may be 
an indication that it depressed the production of irritants and thereby 
reduction in number of writhes in the animlas. The writhing induced by 
chemical substances is due to sensitization of nociceptors by 
prostaglandins. The abdominal constriction response induced by acetic 
acid is a sensitive procedure to establish peripherally acting anti-
nociceptives. This response is thought to involve local peritoneal 
receptors. This result indicates that the analgesic effect of ethanolic 
extract of Luffa acutangula (L) Roxb, might be mediated by inhibiting the 
synthesis or action of prostaglandins. 
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            The centrally acting analgesic activity of the extract was also 
corroborated in our study by tail immersion test results. The fact that in 
thermal stimuli (hot plate & Tail immersion tests), the anti nociceptive 
effect should be shown by acting centrally on opioid receptors. Since the 
drugs had shown the analgesic activity in tail immersion test, it seems 
that the ethanolic extract can act centrally. Taking this in to consideration 
the ethanolic extract of Luffa acutangula (L) Roxb, posses peripheral and 
central analgesic properties. 
          The ethanolic extract of Luffa acutangula (L) Roxb showed anti-
inflammatory activity on an acute inflammatory process like in 
carrageenan induced paw edema in rats paw. It is well known that 
leukocytes migration to the injured tissues in an important aspect of the 
inflammatory process. Histamine and serotonin are responsible for the 
immediate inflammatory response, whereas kinins and prostaglandins 
mediate prolonged response. Anti-inflammatory activity of many plants 
has been attributed to their high sterol/triterpene or flavonoids content. 
The anti-inflammatory effect of ethanolic extract of Luffa acutangula (L) 
Roxb. in rats with carrageenan-induced paw was significant
(66)
. 
            It is known that the inflammatory granuloma is a typical response 
of a chronic inflammatory process and it has been established that the 
weight of the pellets is well correlated with the granulomatous tissue. The 
chronic inflammation occurs by means of the development of 
prolifereative cells. These cells can be either spread or in granuloma 
form. The Luffa acutangula (L) Roxb extract showed significant anti-
inflammtory activity in cotton pellet induced granuloma and thus found to 
be effective in chronic inflammatory conditions. It reflected its efficacy in 
inhibiting the increase in the number of fibroblasts and synthesis of 
collagen and mucopolysaccharide during granuloma tissue formation. 
            Brewer’s yeast was used to induce fever in albino rats. Fever was 
recorded 18 hrs after yeast injection since yeast takes a total of about 18 
hrs to cause the elevation of body temperature. Subcutaneous injection of 
Brewer’s yeast induces pyrexia by increasing the synthesis of 
prostaglandin. It is considered as a useful test for the screening of plants 
materials as well as synthetic drugs for their antipyretic effect. Yeast 
induced pyrexia is called pathogenic fever and its etiology could be the 
production of prostaglandins. The inhibition of prostaglandin synthesis 
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could be the possible mechanism of antipyretic action as that of 
paracetamol and the inhibition of prostaglandin can be achieved by 
blocking the cyclo-oxygenase enzyme activity. There are several 
mediators for pyrexia and the inhibitions of these mediators are 
responsible for the antipyretic effect. 
          The oral administration of Luffa acutangula (L) Roxb significantly 
attenuated rectal temperature of yeast induced albino rats. Thus it can be 
postulated that Luffa acutangula (L) Roxb, contained pharmacologically 
active principles that interfere with the release of prostaglandins. After 
three hours of the test period, the ethanolic leaves extract of Luffa 
acutangula (L) Roxb produced appreciable antipyretic activity against 
brewer’s yeast induced pyrexia in albino rat. It was revealed that the 
extract showed dose dependent antipyretic activity.  
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                                           SUMMARY AND CONCLUSION 
 The present thesis entitled “Evaluation of analgesic, antipyretic and 
anti-inflammatory effect ethanolic leaves extract of Luffa acutangula (L.) 
Roxb.” deals with the exploration of pharmacological and phytochemical 
screening of the selected Indian medicinal plant Luffa acutangula (L.) 
Roxb.  belonging to the family Cucurbitaceae. The results obtained from 
the preliminary phytochemical screening of Luffa acutangula (L.) Roxb. 
extract showed the presence of flavonoids, alkaloids, tannins as shown in 
Table 1. It was reported that the flavonoids frequently found in plants 
posses analgesic, antipyretic and anti-inflammatory activity.  The plant 
was collected and got authentification from Botanical  Survey of  India, 
southern regional centre, Coimbatore with the reference number 
BSI/SRC/5/23/2017/Tech/691. Approval was obtained from committee 
for the purpose of control and supervision of experimental animals 
(CPCSEA) and institutional animal ethics committee (IAEC), proposal 
number NCP/IAEC/NO: 02/2016-17. 
 The plant was shade dried and crushed. It was pulverized and 
extracted with ethanol using soxlet apparatus. The resulting extract was 
concentrated.  The study of the plant Luffa acutangula (L.) Roxb. was 
done by using mice  with the oral doses of  5, 50, 100, 1000 & 2000 mg/ 
kg body weight of extract and no mortality was observed for 24 hours. 
Thus dose was identified as per OECD 423 Guidlines. 
 As for the analgesic effect, the leaf extract appear to act via the 
central and peripheral mechanisms of analgesia by using hot plate, tail 
immersion and Acetic acid induced writhing animal model. Antipyretic 
activity of leaves extract was done by using yeast induced pyrexia 
method and finally anti-inflammatory effect of plant extract was done by 
using carrageenan- induced paw edema in rats and cotton pellet 
granuloma techniques. 
 The Luffa acutangula (L.) Roxb. has shown a significant anti-
inflammatory, anti- pyretic and analgesic effects. These effects maybe 
because of the presence of phytochemicals such as flavonoids, tannins 
and terpenoids present in the plant extract  
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 The Present study showed that the ethanolic leaves extract of Luffa 
acutangula (L) Roxb, posses peripheral and central analgesic activity in 
animal model. The Luffa acutangula (L) Roxb leaves extract shows anti-
pyretic activity in animal model in rats and Luffa acutangula (L) Roxb 
showed anti-inflammatory activity in different animal model. Flavonoids 
and tannins are the major constituents of Luffa acutangula (L) Roxb 
leaves, which may be responsible for its Analgesic, Anti-pyretic and 
Anti-inflammatory activity. 
Further detailed study on Luffa acutangula (L) Roxb plant using 
different flogestic agents in this area will enable us to understand the 
mechanism of action underline the above mention activity. 
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